Letermovir for pre-emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation.
Raena KaurDuncan PurtillJulian CooneyPaul CannellMatthew WrightTandy-Sue CopelandMatthew McGuirePeter A BoanPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
LTV was effective in controlling CMV viremia when it was given at a lower starting CMV viral load and later post alloHCT than VGC. Further study is required of LTV as upfront PET following alloHCT.